Overview |
bs-2656R-Cy7 |
LIR-6 Polyclonal Antibody, Cy7 Conjugated |
IF(IHC-P), IF(IHC-F), IF(ICC) |
Human |
Specifications |
Cy7 |
Rabbit |
KLH conjugated synthetic peptide derived from human LIR6 |
401-489/489 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
Cell membrane |
CD85 antigen-like family member I; CD85i; Leukocyte immunoglobulin-like receptor 6; Leukocyte immunoglobulin-like receptor subfamily A member 1; Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1; Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 soluble isoform; LILRA1; LIR-6; LIR6; LIRA1_HUMAN. |
May act as receptor for class I MHC antigens. |
Application Dilution |
IF(IHC-P) |
1:50-200 |
IF(IHC-F) |
1:50-200 |
IF(ICC) |
1:50-200 |